THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS

THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS

Goal: to evaluate the efficacy and safety of domestic (home-produced) recombinant factor VIIa (Coagil VII) for massive bleeding and haemostasis disordes treatment in thoracic aorta surgery. Methods. 82 patients undergoing surgery on thoracic aorta with cardiopulmonary bypass and circulatory arrest s...

Full description

Bibliographic Details
Main Authors: N. A. TREKOVA, D. A. GUSKOV, A. V. GONCHAROVA, B. A. AKSELROD
Format: Article
Language:Russian
Published: New Terra Publishing House 2019-07-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
recombinant activated factor vii
coagil vii
ascending aortic and aortic arch surgery
hemostasis
Online Access:https://www.vair-journal.com/jour/article/view/333

Internet

https://www.vair-journal.com/jour/article/view/333

Similar Items